IN THE SEMICONDUCTOR industry, Arm is everywhere and nowhere. Designs from the British-based, American-listed, Japanese-controlled firm sit in almost all the world’s smartphones and most other ...

Arm shares slid after hours after licensing revenue narrowly missed estimates. AI demand lifted total revenue to a quarterly record, beating forecasts. Smartphone exposure remains a risk as memory ...

Gaming Laptops Nvidia's long-awaited N1X Arm chip for consumer PCs spotted in a near retail-ready Dell laptop Operating Systems Microsoft's Xbox app has been released for Arm PCs—just in time for ...

Deadline’s Read the Screenplay series spotlighting the scripts behind the year’s most talked-about movies continues with the Venice Film Festival-premiering Frankenstein, Netflix’s epic drama and long ...

Microsoft and Qualcomm have made important improvements to compatibility and performance for games on Snapdragon CPUs. Microsoft and Qualcomm have made important improvements to compatibility and ...

Hardware Valve quickly updates its own Steam Machine update, recommitting to a 2026 launch despite AI woes: 'Nothing's really changed on our end' Gaming Industry Valve says Steam users downloaded 100 ...

83, of Louisville, KY, passed away at home surrounded by his loving family on September 11, 2025. Born in Louisville on April 26, 1942, to Adele and S. Harry Linker, Steve was a man of compassion, ...

Arm has just unveiled its next-gen processor technologies for upcoming smartphones, which could potentially land in consumer hands as soon as the end of the year. As usual, we have new CPU and GPU ...

Arm Holdings (NASDAQ:ARM) drew investor attention on Wednesday as optimism over artificial intelligence continued to drive activity across semiconductor stocks. The British chipmaker, whose ...

This tutorial shows how to draw anime arms, covering anatomy, proportions, and shading. A step-by-step guide for improving arm drawings in manga and anime character art. Gavin Newsom signs California ...

A panelist discusses early clinical trial data on combining the B-cell maturation antigen–targeting bispecific antibody linvoseltamab with proteasome inhibitors carfilzomib and bortezomib in ...